Jenburkt Pharmaceuticals Limited reported earnings results for the third quarter and nine months ended December 31, 2021. For the third quarter, the company reported sales was INR 330.02 million compared to INR 318.19 million a year ago. Revenue was INR 342.87 million compared to INR 328.69 million a year ago. Net income was INR 62.27 million compared to INR 59.46 million a year ago. Basic earnings per share from continuing operations was INR 13.57 compared to INR 12.96 a year ago.
For the nine months, sales was INR 956.9 million compared to INR 797.35 million a year ago. Revenue was INR 993.61 million compared to INR 827.83 million a year ago. Net income was INR 188.48 million compared to INR 126.26 million a year ago. Basic earnings per share from continuing operations was INR 41.07 compared to INR 27.51 a year ago.